Spago Nanomedical AB (publ) (STO:SPAGO)

Spago Nanomedical AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	32.51	29.67	32.47	45.22	62.1	52.46
Cash & Short-Term Investments	32.51	29.67	32.47	45.22	62.1	52.46
Cash Growth	75.56%	-8.62%	-28.19%	-27.19%	18.38%	84.41%
Accounts Receivable	-	-	0.2	0.37	0.05	0.04
Other Receivables	0.22	4.95	4.46	3.58	0.66	0.86
Receivables	0.22	4.95	4.66	3.95	0.71	0.89
Prepaid Expenses	3.33	1.32	1.46	2.74	2.43	1.03
Other Current Assets	0.77	-	-0	-0	-	-
Total Current Assets	36.83	35.94	38.59	51.91	65.24	54.39
Property, Plant & Equipment	0.11	0.14	0.61	0.93	0.85	1.08
Long-Term Investments	-	-	-	-	0	-
Other Intangible Assets	-	-	-	-	8.11	7.31
Long-Term Deferred Charges	-	-	-	-	131.74	128.85
Other Long-Term Assets	0.73	0.61	0.38	0.15	-0	-
Total Assets	37.66	36.68	39.58	52.99	205.95	191.62

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.48	3.16	2.72	6.39	4.73	3.86
Accrued Expenses	2.28	1.15	1.82	1.53	1.56	1.49
Other Current Liabilities	0.32	0.85	1.32	3.56	2.51	1.47
Total Current Liabilities	5.08	5.17	5.86	11.48	8.8	6.81
Pension & Post-Retirement Benefits	0.73	0.61	0.38	0.15	-	-
Other Long-Term Liabilities	0.19	0.16	0.1	0.04	-	-
Total Liabilities	5.99	5.94	6.35	11.67	8.8	6.81

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	7.98	6.62	3.48	18.86	90.94	41.18
Additional Paid-In Capital	316.75	303.4	282.1	270.56	257.15	255.37
Retained Earnings	-	-	-	-	-150.93	-111.74
Comprehensive Income & Other	-293.06	-279.27	-252.35	-248.1	-	-
Total Common Equity	31.67	30.75	33.24	41.32	197.16	184.81
Shareholders' Equity	31.67	30.75	33.24	41.32	197.16	184.81
Total Liabilities & Equity	37.66	36.68	39.58	52.99	205.95	191.62

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash (Debt)	32.51	29.67	32.47	45.22	62.1	52.46
Net Cash Growth	75.56%	-8.62%	-28.19%	-27.19%	18.38%	84.41%
Net Cash Per Share	0.06	0.08	0.09	0.46	0.97	1.33
Filing Date Shares Outstanding	798.38	661.57	348.2	219.51	90.94	41.18
Total Common Shares Outstanding	798.38	661.57	348.2	219.51	90.94	41.18
Working Capital	31.75	30.77	32.72	40.43	56.45	47.58
Book Value Per Share	0.04	0.05	0.10	0.19	2.17	4.49
Tangible Book Value	31.67	30.75	33.24	41.32	189.04	177.5
Tangible Book Value Per Share	0.04	0.05	0.10	0.19	2.08	4.31
Machinery	-	1.44	4.27	4.8	4.45	4.31

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error